RhumbLine Advisers’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-260,584
| Closed | -$22.1M | – | 2967 |
|
|
2019
Q4 | $22.1M | Buy |
260,584
+22,098
| +9% | +$1.47M | 0.04% | 445 |
|
|
2019
Q3 | $11.9M | Buy |
238,486
+16,903
| +8% | +$674K | 0.02% | 689 |
|
|
2019
Q2 | $8.08M | Buy |
221,583
+25,855
| +13% | +$844K | 0.02% | 910 |
|
|
2019
Q1 | $5.47M | Buy |
195,728
+107
| +0.1% | +$2.52K | 0.01% | 1124 |
|
|
2018
Q4 | $3.74M | Buy |
195,621
+35,238
| +22% | +$820K | 0.01% | 1272 |
|
|
2018
Q3 | $4.8M | Sell |
160,383
-2,758
| -2% | -$104K | 0.01% | 1135 |
|
|
2018
Q2 | $5.99M | Buy |
163,141
+4,642
| +3% | +$151K | 0.01% | 982 |
|
|
2018
Q1 | $5.22M | Buy |
158,499
+2,139
| +1% | +$66.8K | 0.01% | 1012 |
|
|
2017
Q4 | $4.28M | Buy |
156,360
+14,090
| +10% | +$434K | 0.01% | 1171 |
|
|
2017
Q3 | $5.27M | Sell |
142,270
-3,335
| -2% | -$123K | 0.01% | 997 |
|
|
2017
Q2 | $5.53M | Buy |
145,605
+58
| +0% | +$2.58K | 0.01% | 949 |
|
|
2017
Q1 | $7.12M | Buy |
145,547
+40,945
| +39% | +$1.87M | 0.02% | 811 |
|
|
2016
Q4 | $3.55M | Buy |
104,602
+3,906
| +4% | +$139K | 0.01% | 1123 |
|
|
2016
Q3 | $3.8M | Buy |
100,696
+5,323
| +6% | +$201K | 0.01% | 1041 |
|
|
2016
Q2 | $3.21M | Sell |
95,373
-27,537
| -22% | -$971K | 0.01% | 1061 |
|
|
2016
Q1 | $3.9M | Buy |
122,910
+10,790
| +10% | +$352K | 0.01% | 975 |
|
|
2015
Q4 | $4.19M | Buy |
112,120
+5,080
| +5% | +$192K | 0.01% | 912 |
|
|
2015
Q3 | $4.06M | Buy |
107,040
+4,060
| +4% | +$143K | 0.01% | 915 |
|
|
2015
Q2 | $2.95M | Buy |
102,980
+18,065
| +21% | +$503K | 0.01% | 1156 |
|
|
2015
Q1 | $2.38M | Buy |
84,915
+8,315
| +11% | +$234K | 0.01% | 1287 |
|
|
2014
Q4 | $2.12M | Sell |
76,600
-2,415
| -3% | -$59.8K | 0.01% | 1321 |
|
|
2014
Q3 | $1.76M | Sell |
79,015
-2,510
| -3% | -$63.7K | 0.01% | 1406 |
|
|
2014
Q2 | $2.37M | Buy |
81,525
+691
| +0.9% | +$18.5K | 0.01% | 1258 |
|
|
2014
Q1 | $2.3M | Sell |
80,834
-2,970
| -4% | -$98.3K | 0.01% | 1259 |
|
|
2013
Q4 | $3.24M | Buy |
83,804
+4,330
| +5% | +$155K | 0.01% | 1063 |
|
|
2013
Q3 | $2.66M | Buy |
79,474
+2,449
| +3% | +$78K | 0.01% | 1165 |
|
|
2013
Q2 | $2.37M | Buy |
+77,025
| New | +$2.58M | 0.01% | 1194 |
|
Other funds holding MDCO
RhumbLine Advisers's MDCO Position: Q1 2020 in Review
RhumbLine Advisers sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 260,584 shares — an estimated $22.1M sold.
RhumbLine Advisers first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $22.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- RhumbLine Advisers reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- RhumbLine Advisers sold 260,584 Medicines Co shares in Q1 2020, an estimated $22.1M.
- RhumbLine Advisers first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- RhumbLine Advisers's Medicines Co position peaked at $22.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.